Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News AbbVie makes bold move in Alzheimer’s market with $1.4bn Aliada buyout—Is it a gamble? AbbVie, the renowned American biopharmaceutical giant, is set to acquire Aliada Therapeutics for a staggering $1.4 billion. The… byPallavi MadhirajuOctober 28, 2024